Fibronostics
Curated by SignalNon-invasive algorithm-based diagnostics
Overview
Non-invasive algorithm-based diagnostics. The company uses machine learning to target specific physiological and pathological processes, in order to assess subclinical biomarker profiles in plasma for diagnosis and prognosis of disease pathologies. Applications under investigation include cardiometabolic diseases, idiopathic pulmonary fibrosis, and chronic renal diseases.
Key facts
- Founded
- 2015
- Headquarters
- Orlando, United States
- Stage
- Sign up to view
- Industry
- Life Sciences Technology
Business model
- 1 product or service
- Sign up to view